Shares of Genus plc (LON:GNS - Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 2,665 ($35.96) and last traded at GBX 2,655 ($35.82), with a volume of 198722 shares changing hands. The stock had previously closed at GBX 2,610 ($35.21).
Wall Street Analyst Weigh In
A number of analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft boosted their price target on Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a research report on Tuesday, July 15th. Shore Capital restated a "buy" rating and issued a GBX 2,750 target price on shares of Genus in a report on Tuesday, July 15th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Genus presently has a consensus rating of "Buy" and a consensus target price of GBX 2,650.
Get Our Latest Report on Genus
Genus Stock Performance
The stock has a market cap of £1.73 billion, a price-to-earnings ratio of 218.42, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The stock's 50-day simple moving average is GBX 2,275.66 and its two-hundred day simple moving average is GBX 2,011.01.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access